Apart from retrospective evaluation of the absorbed dose in cases of accidental exposure to IR for which it seems to be generally not very useful, the γ-H2AX assay has widespread clinical and preclinical applications on translational cancer research to measure the biological effects of DNA damaging agents used in both chemotherapy and radiotherapy (Ivashkevich et al. 2012). Here, H2AX is linked to cancer.